The PGA Tour announced a six-month suspension against professional golfer Trey Mullinax on Wednesday following a positive test for a substance on the World Anti-Doping Agency’s prohibited list. The 34-year-old competitor is barred from competing on the tour until January 16, 2027.
In a statement, Mullinax acknowledged responsibility for the violation, explaining that he had recently used medication to treat a condition originally diagnosed during his college years without obtaining proper approval under the tour’s anti-doping regulations. He emphasized that his lack of familiarity with the approval process did not excuse his actions and that he should have reviewed the policy requirements before administering any medication. Mullinax stressed that he had never intentionally used performance-enhancing substances to gain competitive advantage and expressed his deep respect for golf and its values.
The golfer’s competitive activity has been limited in recent months. Through the calendar year, he made two starts on the PGA Tour and competed once on the Korn Ferry Tour, with his most recent appearance coming at the Zurich Classic of New Orleans team event in April. Mullinax’s last PGA Tour victory came in 2022 at the Barbasol Championship. His recent years have been marked by ongoing health challenges that have impacted his ability to perform at previous levels. In the most recent competitive season prior to the suspension announcement, he registered four top-25 finishes across 23 PGA Tour appearances but was unable to secure full playing privileges through PGA Tour Qualifying School.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI